Skip to main content
. 2017 Aug 10;8(45):79884–79896. doi: 10.18632/oncotarget.20168

Figure 6. Prevalence of systemic inflammation by cancer site, as determined by % patients with elevated blood levels of C-reactive protein (N=1087).

Figure 6

M0 = stage I-III, M1 = stage IV. P<0.001 among cancer site groups.